CAD 0.04
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -764 Thousand CAD | 3.17% |
2022 | -792.36 Thousand CAD | 1.98% |
2021 | -808.36 Thousand CAD | 24.79% |
2020 | -1.07 Million CAD | -28.83% |
2019 | -834.31 Thousand CAD | -102.15% |
2018 | -412.71 Thousand CAD | -707.82% |
2017 | -51.09 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -130.25 Thousand CAD | 14.59% |
2024 Q1 | -152.5 Thousand CAD | 31.06% |
2023 Q4 | -221.21 Thousand CAD | -37.71% |
2023 Q2 | -252.5 Thousand CAD | -52.58% |
2023 FY | -767.25 Thousand CAD | 3.17% |
2023 Q1 | -165.49 Thousand CAD | 7.23% |
2023 Q3 | -160.63 Thousand CAD | 36.38% |
2022 Q2 | -216.34 Thousand CAD | -7.95% |
2022 Q4 | -178.4 Thousand CAD | 9.54% |
2022 FY | -792.36 Thousand CAD | 1.98% |
2022 Q1 | -200.4 Thousand CAD | 13.04% |
2022 Q3 | -197.21 Thousand CAD | 8.84% |
2021 FY | -808.36 Thousand CAD | 24.79% |
2021 Q2 | -215.64 Thousand CAD | -34.06% |
2021 Q4 | -230.46 Thousand CAD | -13.43% |
2021 Q3 | -203.17 Thousand CAD | 5.78% |
2021 Q1 | -160.85 Thousand CAD | 18.94% |
2020 Q4 | -198.43 Thousand CAD | 2.04% |
2020 Q3 | -202.55 Thousand CAD | 66.57% |
2020 Q2 | -605.92 Thousand CAD | -413.53% |
2020 FY | -1.07 Million CAD | -28.83% |
2020 Q1 | -117.99 Thousand CAD | 61.12% |
2019 Q2 | -204.45 Thousand CAD | -31.49% |
2019 Q1 | -155.49 Thousand CAD | -11.31% |
2019 FY | -834.31 Thousand CAD | -102.15% |
2019 Q4 | -303.45 Thousand CAD | -48.36% |
2019 Q3 | -204.53 Thousand CAD | -0.04% |
2018 Q2 | -127.97 Thousand CAD | -69.42% |
2018 Q3 | -69.67 Thousand CAD | 45.55% |
2018 FY | -412.71 Thousand CAD | -707.82% |
2018 Q4 | -139.68 Thousand CAD | -100.48% |
2018 Q1 | -75.53 Thousand CAD | -48.95% |
2017 Q4 | -50.71 Thousand CAD | -13174.87% |
2017 FY | -51.09 Thousand CAD | 0.0% |
2017 Q3 | -382.00 CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | 35.849% |
Ayurcann Holdings Corp. | -3.25 Million CAD | 76.498% |
Blueberries Medical Corp. | -1.22 Million CAD | 37.712% |
The BC Bud Corporation | -1.22 Million CAD | 37.554% |
BioNxt Solutions Inc. | -6.36 Million CAD | 88.001% |
CordovaCann Corp. | -2.51 Million CAD | 69.592% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 13.235% |
Captor Capital Corp. | 655.2 Thousand CAD | 216.605% |
City View Green Holdings Inc. | -996.45 Thousand CAD | 23.327% |
1CM Inc. | 300.79 Thousand CAD | 354.0% |
Global Hemp Group Inc. | -551.7 Thousand CAD | -38.481% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 80.304% |
IM Cannabis Corp. | -12.17 Million CAD | 93.725% |
Lobe Sciences Ltd. | -3.35 Million CAD | 77.258% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -94.793% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 76.02% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 240.891% |
Pharmadrug Inc. | -1.33 Million CAD | 42.771% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | 33.098% |
RAMM Pharma Corp. | -7.08 Million CAD | 89.218% |
RIV Capital Inc. | 1.78 Million CAD | 142.916% |
Revive Therapeutics Ltd. | -3.28 Million CAD | 76.75% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 91.287% |
SLANG Worldwide Inc. | -5.98 Million CAD | 87.238% |
1933 Industries Inc. | -9.34 Million CAD | 91.828% |
Red Light Holland Corp. | -6.44 Million CAD | 88.148% |
Top Strike Resources Corp. | -784.8 Thousand CAD | 2.65% |
Xebra Brands Ltd. | -1.55 Million CAD | 50.853% |
Adastra Holdings Ltd. | -1.79 Million CAD | 57.407% |